Lung Cancer

PBS listing provides new chemo plus immunotherapy option for stage IV lung cancer

Nivolumab (Opdivo) plus ipilimumab (Yervoy) in combination with two cycles of platinum-doublet chemotherapy has been added to the PBS for patients with previously untreated squamous stage IV non-small cell lung cancer (NSCLC) who are EGFR and ALK negative. The PBS listing is supported by evidence including the recently published CheckMate 9LA study which found the ...

Already a member?

Login to keep reading.

© 2022 the limbic